Latest Insider Transactions at Singular Genomics Systems, Inc. (OMIC)
This section provides a real-time view of insider transactions for Singular Genomics Systems, Inc. (OMIC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Singular Genomics Systems, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Singular Genomics Systems, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2023
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+0.16%
|
-
|
|
Dec 15
2023
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+3.12%
|
-
|
|
Dec 15
2023
|
Sam Ropp Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,188
+25.0%
|
-
|
|
Nov 17
2023
|
Andrew Spaventa Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
75,000
+1.81%
|
$0
$0.42 P/Share
|
|
Nov 16
2023
|
Eli N. Glezer Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
200,000
+4.19%
|
$0
$0.43 P/Share
|
|
Nov 16
2023
|
Andrew Spaventa Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
43,468
+1.08%
|
$0
$0.41 P/Share
|
|
Sep 15
2023
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
14,584
+0.37%
|
-
|
|
Sep 15
2023
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
14,584
-59.89%
|
-
|
|
Sep 15
2023
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,584
+37.46%
|
-
|
|
Sep 15
2023
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+0.17%
|
-
|
|
Sep 15
2023
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+3.22%
|
-
|
|
Sep 15
2023
|
Sam Ropp Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,187
+33.33%
|
-
|
|
Aug 15
2023
|
Kim P. Kamdar |
SELL
Open market or private sale
|
Indirect |
200,000
-5.05%
|
$0
$0.53 P/Share
|
|
Aug 14
2023
|
Kim P. Kamdar |
SELL
Open market or private sale
|
Indirect |
77,991
-1.93%
|
$0
$0.57 P/Share
|
|
Aug 11
2023
|
Kim P. Kamdar |
SELL
Open market or private sale
|
Indirect |
353,657
-8.05%
|
$0
$0.6 P/Share
|
|
Jun 15
2023
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+0.17%
|
-
|
|
Jun 15
2023
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+3.33%
|
-
|
|
Jun 15
2023
|
Sam Ropp Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,188
+50.0%
|
-
|
|
Jun 15
2023
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
14,583
+0.37%
|
-
|
|
Jun 15
2023
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
14,583
-59.89%
|
-
|
|
Jun 15
2023
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,583
+37.46%
|
-
|
|
May 17
2023
|
Eli N. Glezer Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
170,000
+3.76%
|
$0
$0.82 P/Share
|
|
Dec 12
2022
|
Eli N. Glezer Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+1.18%
|
$100,000
$2.0 P/Share
|
|
Jul 07
2022
|
David L Barker |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+50.0%
|
$0
$0.63 P/Share
|
|
May 31
2022
|
Michael J Pellini |
SELL
Bona fide gift
|
Direct |
154,939
-60.94%
|
-
|
|
May 31
2022
|
Michael J Pellini |
BUY
Exercise of conversion of derivative security
|
Direct |
154,939
+20.53%
|
$0
$0.36 P/Share
|
|
May 18
2022
|
Michael J Pellini |
BUY
Open market or private purchase
|
Direct |
26,834
+21.28%
|
$80,502
$3.3 P/Share
|
|
Mar 24
2022
|
Andrew Spaventa Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
9,766
+50.0%
|
-
|
|
Mar 24
2022
|
Andrew Spaventa Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
173,144
-100.0%
|
-
|
|
Dec 02
2021
|
Andrew Spaventa Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
715,884
-80.52%
|
-
|
|
Jun 01
2021
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,500,000
+22.45%
|
$33,000,000
$22.0 P/Share
|
|
Jun 01
2021
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
7,612,019
+35.86%
|
$129,404,323
$17.6 P/Share
|
|
Jun 01
2021
|
Kim P. Kamdar |
BUY
Conversion of derivative security
|
Indirect |
4,395,633
+49.44%
|
-
|
|
Jun 01
2021
|
Alexandria Venture Investments, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,645,985
+50.0%
|
-
|
|
Jun 01
2021
|
Andrew Spaventa Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
889,028
+33.15%
|
$15,113,476
$17.6 P/Share
|
|
May 20
2021
|
Michael J Pellini |
BUY
Conversion of derivative security
|
Indirect |
96,944
+50.0%
|
-
|